Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Moharregh Khiabani, Darius ^a   Blank, Alexander ^a   Skripuletz, Thomas ^a   Miller, Elvira ^a   Kotsiari, Alexandra ^a   Gudi, Viktoria ^a,b   Stangel, Martin ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC DICARBOXYLIC ACID; CUPRIZONE; DIMETHYLFUMARIC ACID; FUMARIC ACID; LIPOPOLYSACCHARIDE; MONOMETHYLFUMARATE; NITRIC OXIDE; UNCLASSIFIED DRUG; CITRACONIC ACID; FUMARIC ACID DERIVATIVE; FUMARIC ACID DIMETHYL ESTER; MALEIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL PROTECTION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; DRUG EFFECT; DRUG MECHANISM; GLIA CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE MIGRATION; MALE; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; RAT; REMYELINIZATION; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DEMYELINATING DISEASE; IMMUNOHISTOCHEMISTRY; METABOLISM; MONONUCLEAR CELL; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CUPRIZONE; DEMYELINATING DISEASES; FUMARATES; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; MALE; MALEATES; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77955478688     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011769     Document Type: Article

References (34)

1. Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31: 247-269.
2. Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, et al. (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 372: 1463-1472.
3. Linker RA, Lee DH, Stangel M, Gold R (2008) Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies. Expert Rev Neurother 8: 1683-1690.
4. Treumer F, Zhu K, Glaser R, Mrowietz U (2003) Dimethylfumarate is a potent inducer of apoptosis in human T cells. J Invest Dermatol 121: 1383-1388.
5. Mrowietz U, Asadullah K (2005) Dimethylfumarate for psoriasis: more than a dietary curiosity. Trends Mol Med 11: 43-48.
6. Litjens NH, Rademaker M, Ravensbergen B, Rea D, van der Plas MJ, et al. (2004) Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol 34: 565-575.
7. Zhu K, Mrowietz U (2001) Inhibition of dendritic cell differentiation by fumaric acid esters. J Invest Dermatol 116: 203-208.
8. Schilling S, Goelz S, Linker R, Luehder F, Gold R (2006) Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin Exp Immunol 145: 101-107.
9. Wierinckx A, Breve J, Mercier D, Schultzberg M, Drukarch B, et al. (2005) Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol 166: 132-143.
10. Lehmann JC, Listopad JJ, Rentzsch CU, Igney FH, von Bonin A, et al. (2007) Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol 127: 835-845.
11. Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11: 107-116.
12. Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, et al. (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172: 1053-1061.
13. Lindner M, Heine S, Haastert K, Garde N, Fokuhl J, et al. (2008) Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol Appl Neurobiol 34: 105-114.
14. Norkute A, Hieble A, Braun A, Johann S, Clarner T, et al. (2009) Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J Neurosci Res 87: 1343-1355.
15. Rehbinder C, Baneux P, Forbes D, van Herck H, Nicklas W, et al. (1996) FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guinea pig and rabbit experimental units. Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health accepted by the FELASA Board of Management, November 1995. Lab Anim 30: 193-208.
16. Lindner M, Trebst C, Heine S, Skripuletz T, Koutsoudaki PN, et al. (2008) The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination. Glia 56: 1104-1113.
17. Paxinos G, Franklin KBJ (2001) The Mouse Brain in Stereotaxic Coordinates. Academic Press.
18. Stangel M, Bernard D (2003) Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination. J Neuroimmunol 138: 25-30.
19. Louis JC, Magal E, Muir D, Manthorpe M, Varon S (1992) CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J Neurosci Res 31: 193-204.
20. Schubert D, Heinemann S, Carlisle W, Tarikas H, Kimes B, et al. (1974) Clonal cell lines from the rat central nervous system. Nature 249: 224-227.
21. Heine S, Ebnet J, Maysami S, Stangel M (2006) Effects of interferon-beta on oligodendroglial cells. J Neuroimmunol 177: 173-180.
22. Nociari MM, Shalev A, Benias P, Russo C (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods 213: 157-167.
23. Stangel M, Compston A, Scolding NJ (2000) Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins (''IVIg''). J Neuroimmunol 103: 195-201.
24. Guevara I, Iwanejko J, Dembinska-Kiec A, Pankiewicz J, Wanat A, et al. (1998) Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 274: 177-188.
25. Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, et al. (2009) Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283: 127-138.
26. Kuhlmann T, Remington L, Maruschak B, Owens T, Bruck W (2007) Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol 66: 238-246.
27. Lindner M, Fokuhl J, Linsmeier F, Trebst C, Stangel M (2009) Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neurosci Lett 453: 120-125.
28. Skripuletz T, Bussmann JH, Gudi V, Koutsoudaki PN, Pul R, et al. (2009) Cerebellar Cortical Demyelination in the Murine Cuprizone Model. Brain Pathol.
29. Torkildsen O, Brunborg LA, Myhr KM, Bo L (2008) The cuprizone model for demyelination. Acta Neurol Scand Suppl 188: 72-76.
30. Kondo A, Nakano T, Suzuki K (1987) Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice. Brain Res 425: 186-190.
31. Bakker DA, Ludwin SK (1987) Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases. J Neurol Sci 78: 125-137.
32. Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, et al. (2004) Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 164: 1673-1682.
33. Yang HJ, Wang H, Zhang Y, Xiao L, Clough RW, et al. (2009) Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia. Brain Res 1270: 121-130.
34. Cammer W (1999) The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro. J Neurol Sci 168: 116-120.